Caris Life Sciences (CAI) Amortizatization of Intangibles (2024 - 2026)
Caris Life Sciences' (CAI) quarterly Amortizatization of Intangibles came in at $2.6 million in Q1 2026, up 34.91% year-on-year from $1.9 million in Q1 2025, and up 333.72% quarter-over-quarter from $605000.0 in Q4 2025.
Caris Life Sciences (CAI) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Caris Life Sciences' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $2.6 million for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 34.91% year-over-year to $2.6 million in Q1 2026; TTM through Mar 2026 was $13.4 million, a 81.5% increase from a year earlier, with the FY2025 full-year figure at $12.8 million, up 81.0% from the prior year.
- Amortizatization of Intangibles rose to $2.6 million in Q1 2026 per CAI's latest filing, from $605000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $7.8 million in Q2 2025 and bottomed at $605000.0 in Q4 2025.
- The 3-year median for Amortizatization of Intangibles is $1.9 million (2024), against an average of $2.6 million.
- Biggest YoY gain for Amortizatization of Intangibles was 348.01% in 2025; the steepest drop was 68.26% in 2025.
- Year by year, Amortizatization of Intangibles stood at $1.9 million in 2024, then slumped by 68.26% to $605000.0 in 2025, then surged by 333.72% to $2.6 million in 2026.
- Per Business Quant, the three latest CAI Amortizatization of Intangibles figures stand at $2.6 million (Q1 2026), $605000.0 (Q4 2025), and $2.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Caris Life Sciences | 4.41 Bn | 3.58 Bn | 214.23 Mn | 2.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.62 Mn |
| Mar 31, 2026 | 2.62 Mn |
| Dec 31, 2025 | 605,000.00 |
| Dec 31, 2025 | 605,000.00 |
| Sep 30, 2025 | 2.46 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | 7.76 Mn |
| Jun 30, 2025 | 7.76 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Mar 31, 2025 | 1.95 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.73 Mn |